TWIST1
Twist-related protein 1
Also known as: ACS3, bHLHa38, BPES2, BPES3, CRS, CRS1, H-twist, SCS, TWIST, TWST1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15672
- Gene
- TWIST1
- Ensembl
- ENSG00000122691
- Chromosome
- 7
- Canonical length
- 202 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a basic helix-loop-helix (bHLH) transcription factor that plays an important role in embryonic development. The encoded protein forms both homodimers and heterodimers that bind to DNA E box sequences and regulate the transcription of genes involved in cranial suture closure during skull development. This protein may also regulate neural tube closure, limb development and brown fat metabolism. This gene is hypermethylated and overexpressed in multiple human cancers, and the encoded protein promotes tumor cell invasion and metastasis, as well as metastatic recurrence. Mutations in this gene cause Saethre-Chotzen syndrome in human patients, which is characterized by craniosynostosis, ptosis and hypertelorism. [provided by RefSeq, Jul 2020]
Canonical amino-acid sequenceUniProt
202 residues, UniProt reviewed canonical sequence.
>Q15672|TWIST1
1 MMQDVSSSPV SPADDSLSNS EEEPDRQQPP SGKRGGRKRR SSRRSAGGGA GPGGAAGGGV
61 GGGDEPGSPA QGKRGKKSAG CGGGGGAGGG GGSSSGGGSP QSYEELQTQR VMANVRERQR
121 TQSLNEAFAA LRKIIPTLPS DKLSKIQTLK LAARYIDFLY QVLQSDELDS KMASCSYVAH
181 ERLSYAFSVW RMEGAWSMSA SHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TWIST1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- breast: 25 nTPM
- adipose tissue: 21 nTPM
- endometrium: 18 nTPM
- skin: 16 nTPM
- blood vessel: 14 nTPM
- placenta: 12 nTPM
Single-cell type
- fibroblasts: 109 nCPM
- endometrial stromal cells: 86 nCPM
- adipocytes: 78 nCPM
- smooth muscle cells: 59 nCPM
- pericytes: 52 nCPM
- fibro-adipogenic progenitors: 31 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 2.9 nTPM
- cerebral cortex: 2.7 nTPM
- midbrain: 2.2 nTPM
- amygdala: 1.9 nTPM
- white matter: 1.7 nTPM
- pons: 1.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TWIST1.
Disease | AllUniProt
Conditions TWIST1 is implicated in, by any mechanism.
- Saethre-Chotzen syndrome (SCS) MIM:101400
- Robinow-Sorauf syndrome (RSS) MIM:180750
- Craniosynostosis 1 (CRS1) MIM:123100
- Sweeney-Cox syndrome (SWCOS) MIM:617746
Disease | GeneticClinVar
97 pathogenic / likely-pathogenic of 271 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Saethre-Chotzen syndrome
- TWIST1-related craniosynostosis
- TWIST1-related disorder
- Sweeney-Cox syndrome
- Robinow-Sorauf syndrome
Disease | ImmuneIEDB
Conditions an epitope on TWIST1 was assayed in.
- narcolepsy B cell
- multiple sclerosis B cell
- peripheral nervous system disease B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0.34
- gnomAD missense Z
- 1.06
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aortic valve morphogenesis
- cardiac neural crest cell migration involved in outflow tract morphogenesis
- cellular response to hypoxia
- cranial suture morphogenesis
- developmental process
- embryonic camera-type eye formation
- embryonic cranial skeleton morphogenesis
- embryonic digit morphogenesis
- embryonic forelimb morphogenesis
- embryonic hindlimb morphogenesis
- endocardial cushion morphogenesis
- energy homeostasis
- eyelid development in camera-type eye
- in utero embryonic development
- mitral valve morphogenesis
- muscle organ development
- negative regulation of apoptotic process
- negative regulation of cellular senescence
- negative regulation of DNA damage response, signal transduction by p53 class mediator
- negative regulation of DNA-templated transcription
- negative regulation of double-strand break repair
- negative regulation of macrophage cytokine production
- negative regulation of miRNA transcription
- negative regulation of osteoblast differentiation
- negative regulation of peroxisome proliferator activated receptor signaling pathway
- negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- negative regulation of skeletal muscle tissue development
- negative regulation of transcription by RNA polymerase II
- negative regulation of tumor necrosis factor production
- neural tube closure
- neuron migration
- ossification
- osteoblast differentiation
- outer ear morphogenesis
- positive regulation of angiogenesis
- positive regulation of cell migration
- positive regulation of cell motility
- positive regulation of DNA-templated transcription initiation
- positive regulation of epithelial to mesenchymal transition
- positive regulation of fatty acid beta-oxidation
- positive regulation of gene expression
- positive regulation of interleukin-6 production
- positive regulation of monocyte chemotactic protein-1 production
- positive regulation of transcription by RNA polymerase II
- positive regulation of tumor necrosis factor production
- regulation of bone mineralization
- regulation of transcription by RNA polymerase II
- rhythmic process
- cell proliferation involved in heart valve development
- positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
Molecular functions
- bHLH transcription factor binding
- cis-regulatory region sequence-specific DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription factor binding
- DNA-binding transcription repressor activity
- E-box binding
- histone deacetylase binding
- protein domain specific binding
- protein homodimerization activity
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- transcription coregulator binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Myc-type, basic helix-loop-helix (bHLH) domain
- Helix-loop-helix DNA-binding domain superfamily
- E-box Binding Transcriptional Regulators
- Helix-loop-helix DNA-binding domain
- Twist-related protein 1, basic helix-loop-helix domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TWIST1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TWIST1 as an antibody target. Whether an autoantibody or antibody against TWIST1 could matter depends on whether native TWIST1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TWIST1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TWIST1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...